InsidersTradesSigma
沃森生物: directors' dealings · France · AMF
SZSE:300142FR·AMFMcap 17.4Bn€
Explore the full insider trade history of 沃森生物, a listed equity based in France. Shares are quoted on FR FR, under the supervision of AMF. Market capitalisation: €17.4bn. The latest transaction was disclosed on 27 February 2023 — Purchase. Among the most active insiders: 广州盈沃企业管理合伙企业(有限合伙). The full history is free.
13
Insider Decl.
0
Thresholds
·
2 ops.
Buy Volume
·
11 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
13.98 €
Income statement
Revenue2.42 Bn€
Gross profit1.80 Bn€75% margin
Net income177.7 M€7.4% margin
Balance sheet & cash
Market cap17.45 Bn€
Total debt388.6 M€
Free Cash Flow−18.6 M€
Last declaration on 27 February 2023
Declarations13 total
Executives●Purchase22SZSE
667,600 shares
A股XSHE
SZSE:173000006349769820·
Ideal exit: 24 Nov 2023 (T+270)
Executives●Purchase22SZSE
1,968,200 shares
A股XSHE
SZSE:173000006286409570·
Ideal exit: 14 Nov 2023 (T+270)
13 of 13 declarations